about
Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.Severe fatigue: could it be aplastic anemia?Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China.Abnormal immunomodulatory ability on memory T cells in humans with severe aplastic anemia.A novel autologous stem cell procedure for the treatment of aplastic anaemia using reprogrammed mature adult cells: a pilot study.Thymoma followed by aplastic anemia - two different responses to immunosuppressive therapyNot all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practiceRole of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.Aplastic anemia: immunosuppressive therapy in 2010.Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).Effect of Tianshengyuan-1 (TSY-1) on telomerase activity and hematopoietic recovery - in vitro, ex vivo, and in vivo studies.Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.The shortening telomere length of T lymphocytes maybe associated with hyper‑function in servere aplastic anemia.The origin of increasing utilization of hematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (SAD). Introduction.Abnormalities of quantities and functions of linker for activations of T cells in severe aplastic anemia.
P2860
Q34545908-055DF1BC-79D9-4160-9AB5-6A1D2C1F9B3DQ34989207-F1248BCC-3431-42A8-B502-4D4C6A1CB00CQ35088529-2C410D5B-2137-43CD-9E87-4D6CAF642F98Q35740966-597FE757-49BB-41B8-8FA0-E596F60D3693Q36134493-AC71D790-ED02-4FA7-AD15-341E56BF4C1EQ36283101-D74FFC88-EABC-488E-947F-57784FA0B265Q36317960-17C6441B-F3E7-46FB-8884-168F7EE9ED88Q37217855-CC1102D9-5F2B-4F2B-B9F2-9BD1C91C25EAQ37952705-158920FF-338F-421F-9BFC-F297F9CF152EQ38065877-0D1F78D6-BA3F-4039-A81C-26284DA310A3Q38837442-6733C20F-2BA5-4B71-9804-ED70C36A9578Q41489617-200DEBD7-825B-4F9A-A4D5-08E86D6D77C3Q49730181-202EED4A-EE54-4B96-B7A0-E80562D1988EQ53443452-F55833B2-1CF2-46C3-B4D3-28C0072CC928Q54364478-74089D79-7DBD-41AC-99B6-A5EE24A7F7D9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aplastic anemia: pathogenesis and treatment.
@en
type
label
Aplastic anemia: pathogenesis and treatment.
@en
prefLabel
Aplastic anemia: pathogenesis and treatment.
@en
P1476
Aplastic anemia: pathogenesis and treatment.
@en
P2093
Andrea Bacigalupo
P356
10.1182/ASHEDUCATION-2007.1.23
P577
2007-01-01T00:00:00Z